ACADIA Pharmaceuticals Inc

25.09.2026 г., 20:01 ч. UTC

ACADIA Pharmaceuticals shares fell sharply after multiple analysts reduced price targets following disappointing Phase 2 results for Remlifanserin in Alzheimer's disease psychosis.

24.09.2026 г., 22:20 ч. UTC

ACADIA Pharmaceuticals Inc shares have advanced in after-market trading following positive Phase 2 results from the RADIANT trial for Alzheimer's disease psychosis.

23.09.2026 г., 20:01 ч. UTC

ACADIA Pharmaceuticals Inc shares fell, continuing a decline amid broader biotech sector weakness, despite an earlier rebound from a session low.

22.09.2026 г., 20:07 ч. UTC

ACADIA Pharmaceuticals is advancing amid positive biotech sector developments, influenced by Viking Therapeutics' study results and an Overweight rating for Tango Therapeutics.

21.09.2026 г., 22:11 ч. UTC

ACADIA Pharmaceuticals Inc has advanced in after-market trading, gaining notably since Monday's close despite remaining below its 20-day moving average.

18.09.2026 г., 22:46 ч. UTC

ACADIA Pharmaceuticals Inc is down in after-market trading, following earlier losses, and remains below its 20-day moving average amid stagnant U.S. industrial production.

17.09.2026 г., 19:36 ч. UTC

ACADIA Pharmaceuticals Inc shares fell sharply, pulling back from an early high and remaining 4.38% below its 20-day moving average.

16.09.2026 г., 19:16 ч. UTC

ACADIA Pharmaceuticals Inc shares are higher, reaching a notable peak in early afternoon, despite trading below its 20-day moving average.

14.09.2026 г., 20:08 ч. UTC

ACADIA Pharmaceuticals Inc shares are lower today, reflecting broader market declines amid rising crude oil prices and inflation concerns ahead of the Federal Reserve's decision.

9.09.2026 г., 20:07 ч. UTC

ACADIA Pharmaceuticals Inc shares are higher Wednesday, pulling back earlier in the session. Broader market context includes rising crude oil prices above $100.

8.09.2026 г., 20:01 ч. UTC

ACADIA Pharmaceuticals is lower today, driven by significant declines in the Biotechnology sub-sector, reversing recent higher closes since Friday.

3.09.2026 г., 20:02 ч. UTC

ACADIA Pharmaceuticals shares are declining, despite Canaccord Genuity and UBS reiterating Buy ratings and raising price targets amid positive outlooks for its products.

2.09.2026 г., 20:08 ч. UTC

ACADIA Pharmaceuticals is higher today, driven by gains in biotechnology stocks. Earlier, the stock peaked above Tuesday's close before pulling back slightly.

1.09.2026 г., 20:09 ч. UTC

ACADIA Pharmaceuticals is lower in Tuesday trading, in line with broader market declines amid rising oil prices and increasing Treasury yields.

31.08.2026 г., 21:01 ч. UTC

ACADIA Pharmaceuticals is higher in after-market trading, reflecting a notable move since Monday's close amid broader market sentiment on potential interest rate hikes.

28.08.2026 г., 20:07 ч. UTC

ACADIA Pharmaceuticals received EU approval for DAYBU to treat Rett syndrome. Shares are declining despite this development, reflecting unusual volatility during Friday's session.

27.08.2026 г., 23:41 ч. UTC

ACADIA Pharmaceuticals shares are trading lower in after-market hours, despite being above the 20-day moving average and near the upper end of its trading range.

26.08.2026 г., 20:08 ч. UTC

ACADIA Pharmaceuticals is trading lower amid a weaker market following inflation data that may influence future Federal Reserve policy decisions.

25.08.2026 г., 20:07 ч. UTC

Analysts' upgrades boost ACADIA Pharmaceuticals, with Deutsche Bank raising its price target to $38 and Citigroup to $40 following DAYBUE's EU approval.

24.08.2026 г., 20:06 ч. UTC

ACADIA Pharmaceuticals received European Commission approval for DAYBU, the first treatment for Rett syndrome in the EU. Shares are advancing during Monday's session.

21.08.2026 г., 19:56 ч. UTC

ACADIA Pharmaceuticals shares are higher, recovering from an early dip. The move aligns with broader market trends following a surge in Bitcoin prices.

20.08.2026 г., 20:01 ч. UTC

ACADIA Pharmaceuticals shares are lower amid a broader decline in biotechnology stocks, with unusual volatility noted today and cumulative returns down since Wednesday.

19.08.2026 г., 19:46 ч. UTC

ACADIA Pharmaceuticals is trading higher, reflecting positive sentiment in the biotechnology sector amid declining bond yields and increased liquidity, despite a recent pullback.

18.08.2026 г., 20:02 ч. UTC

BMO maintained an Outperform rating on ACADIA Pharmaceuticals with a $36 price target, contributing to positive market sentiment and advancing shares today.

17.08.2026 г., 23:06 ч. UTC

ACADIA Pharmaceuticals shares are trading higher in after-market hours, maintaining a gain while above their 20-day moving average and near a one-month high.

13.08.2026 г., 20:01 ч. UTC

ACADIA Pharmaceuticals Inc shares are lower today, continuing a decline from Wednesday's close. No specific news was identified to explain the movement.

12.08.2026 г., 19:56 ч. UTC

Needham maintained its Buy rating on ACADIA Pharmaceuticals and raised the price target to $41. Shares are trading higher since Tuesday's close.

11.08.2026 г., 19:36 ч. UTC

ACADIA Pharmaceuticals remains near unchanged amid broader market sentiment influenced by geopolitical tensions and upcoming U.S. inflation reports affecting interest rate policy.

7.08.2026 г., 20:06 ч. UTC

ACADIA Pharmaceuticals Inc shares are advancing, maintaining a strong position above the 20-day moving average and near the upper end of their one-month range.

6.08.2026 г., 23:41 ч. UTC

ACADIA Pharmaceuticals shares are higher in after-market trading, reflecting strong performance above its 20-day moving average and nearing the upper end of its one-month range.